Anxiety Disorders — Animal Models & Behavioral Testing

Compare pharmacological, chronic stress, trauma-based, and innate fear models side by side. Match each model to validated anxiety assays and the equipment you need to run them.

Why Animal Models for Anxiety Research

Anxiety disorders are the most prevalent class of psychiatric illness, affecting roughly 300 million people globally. Animal models measure anxiety-like behavior through approach-avoidance conflicts — the tension between an animal's drive to explore and its aversion to exposed, bright, or novel environments. These ethologically grounded assays provide quantifiable, translatable readouts for anxiolytic drug development.

Pharmacological validation models use benzodiazepines (e.g., diazepam) as positive controls to establish assay sensitivity. Chronic stress models produce sustained anxiety phenotypes relevant to generalized anxiety disorder (GAD). Trauma-based models like single prolonged stress (SPS) recapitulate features of post-traumatic stress disorder (PTSD), including enhanced fear conditioning and impaired extinction. Innate fear models using predator odor engage species-typical defense circuits without prior learning.

Model choice depends on the clinical target: acute pharmacological validation for anxiolytic drug screening, chronic corticosterone for GAD-like sustained anxiety, SPS for PTSD-related fear and extinction deficits, and predator odor for innate anxiety circuits that bypass associative learning.

Model Comparison

ModelTypeBackgroundAnxiety-Like BehaviorFear ResponseHPA DysregulationTest WindowBest For
Diazepam ValidationPharmacologicalC57BL/6J or BALB/cJBaseline (untreated)NormalNone30–60 min post-injectionAssay validation; benchmarking novel anxiolytics; establishing dose-response curves; confirming test equipment sensitivity.
Chronic CorticosteronePharmacologicalC57BL/6J3–4 weeksEnhancedChronic HPA activation4–7 weeks of treatmentGAD-like chronic anxiety models; anxiety-depression comorbidity studies; hippocampal neurogenesis and anxiety; anxiolytic screening in a chronic model.
SPS (PTSD)Stress-BasedSprague-Dawley (rat) or C57BL/6J (mouse)7 days post-stressEnhanced acquisition, impaired extinctionEnhanced negative feedback7–14 days post-stressPTSD-specific mechanisms; fear extinction studies; HPA axis negative feedback research; testing treatments that facilitate fear extinction.
Predator OdorEthologicalAny (C57BL/6J, BALB/cJ, Sprague-Dawley)ImmediateInnate (no conditioning needed)Acute HPA activation24 hours to 7 days post-exposureInnate anxiety circuits; BNST and amygdala research; models where conditioning history is a confound; ethologically relevant fear without shock.

Diazepam ValidationPharmacological

Background: C57BL/6J or BALB/cJ

Anxiety-Like BehaviorBaseline (untreated)
Fear ResponseNormal
HPA DysregulationNone
Test Window30–60 min post-injection

Not a disease model per se, but the essential positive control for validating any anxiety assay. Diazepam (1–3 mg/kg IP, 30 minutes before testing) increases open arm time on the elevated plus maze, light zone time in the light-dark box, and center time in the open field. Establishes assay sensitivity and benchmarks anxiolytic efficacy for novel compounds. BALB/cJ mice have higher baseline anxiety than C57BL/6J, providing a wider dynamic range.

Ideal for: Assay validation; benchmarking novel anxiolytics; establishing dose-response curves; confirming test equipment sensitivity.

Walf AA, Frye CA. (2007). The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc, 2(2), 322-328. PMID: 17406592

Diazepam Validation Behavioral Battery

Elevated Plus Maze

The gold standard anxiety assay. Diazepam (1–3 mg/kg) reliably increases open arm entries and time. 5-minute test; score open arm time, closed arm time, and entries. BALB/cJ strain maximizes dynamic range.

View Elevated Plus Maze

Light-Dark Box

Approach-avoidance between illuminated (anxiogenic) and dark (safe) compartments. Diazepam increases time in light zone and number of transitions. Simple setup; 5–10 minute test.

View Light-Dark Box

Open Field Test

Center zone time and center entries index anxiety-like behavior. Diazepam increases center exploration without affecting total distance. Also serves as locomotor control for sedation screening.

View Open Field Test

Zero Maze

Elevated annular maze with alternating open and closed quadrants. Eliminates the ambiguous center zone of the plus maze. Diazepam increases open quadrant time. 5-minute test.

View Zero Maze

Chronic CorticosteronePharmacological

Background: C57BL/6J

Anxiety-Like Behavior3–4 weeks
Fear ResponseEnhanced
HPA DysregulationChronic HPA activation
Test Window4–7 weeks of treatment

Corticosterone (35 µg/mL) in drinking water for 4–7 weeks. Produces sustained anxiety-like behavior alongside depressive phenotypes (see Depression page). Anxiety emerges before anhedonia — reduced open arm time on EPM and increased thigmotaxis in open field appear by 3–4 weeks. Models the anxiety-depression comorbidity seen in clinical populations. Non-invasive, consistent, and well-characterized pharmacologically.

Ideal for: GAD-like chronic anxiety models; anxiety-depression comorbidity studies; hippocampal neurogenesis and anxiety; anxiolytic screening in a chronic model.

David DJ, et al. (2009). Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron, 62(4), 479-493. PMID: 19477151

Chronic Corticosterone Behavioral Battery

Elevated Plus Maze

Chronic corticosterone reduces open arm time by 3–4 weeks, modeling sustained GAD-like anxiety. Reversed by chronic SSRI treatment (3+ weeks), not acute dosing.

View Elevated Plus Maze

Light-Dark Box

Reduced light zone time and fewer transitions after chronic corticosterone. Complements EPM with a simpler approach-avoidance readout.

View Light-Dark Box

Open Field Test

Increased thigmotaxis (wall-hugging) and reduced center time. Total distance serves as locomotor control; chronic corticosterone typically does not reduce overall activity.

View Open Field Test

Novel Object Recognition

Chronic corticosterone impairs recognition memory, reflecting hippocampal dysfunction. Links anxiety to cognitive impairment — a key feature of clinical GAD.

View Novel Object Recognition

Zero Maze

Reduced time in open quadrants confirms anxiety-like phenotype. Provides a complementary readout to EPM without center zone ambiguity.

View Zero Maze

SPS (PTSD)Stress-Based

Background: Sprague-Dawley (rat) or C57BL/6J (mouse)

Anxiety-Like Behavior7 days post-stress
Fear ResponseEnhanced acquisition, impaired extinction
HPA DysregulationEnhanced negative feedback
Test Window7–14 days post-stress

A triple-stressor paradigm: 2 hours restraint, 20 minutes forced swim, ether exposure until loss of consciousness, followed by 7 days of undisturbed isolation. Produces enhanced negative feedback of the HPA axis (low baseline cortisol with exaggerated dexamethasone suppression) — the neuroendocrine hallmark of PTSD. Animals show enhanced fear conditioning, impaired fear extinction, exaggerated startle, and anxiety-like behavior on EPM.

Ideal for: PTSD-specific mechanisms; fear extinction studies; HPA axis negative feedback research; testing treatments that facilitate fear extinction.

Lisieski MJ, et al. (2018). Single-prolonged stress: A review of two decades of progress in a rodent model of post-traumatic stress disorder. Front Psychiatry, 9, 196. PMID: 29867615

SPS (PTSD) Behavioral Battery

Fear Conditioning (Extinction)

The defining assay for SPS. Normal fear acquisition but impaired extinction — SPS animals maintain high freezing across extinction sessions while controls reduce freezing. Models the core PTSD feature of persistent traumatic fear.

View Fear Conditioning System

Elevated Plus Maze

Reduced open arm time 7–14 days after SPS. Models generalized anxiety that accompanies PTSD. Important to test after the 7-day incubation period.

View Elevated Plus Maze

Open Field Test

Increased thigmotaxis and reduced center exploration. Hypoactivity may emerge in some protocols. Controls for locomotor effects when interpreting EPM and fear conditioning data.

View Open Field Test

Light-Dark Box

SPS animals spend more time in the dark compartment with fewer light-dark transitions. Provides a complementary anxiety readout to EPM.

View Light-Dark Box

Acoustic Startle

SPS produces exaggerated acoustic startle response and impaired prepulse inhibition. Models the hyperarousal symptom cluster of PTSD.

View Acoustic Startle Chamber

Predator OdorEthological

Background: Any (C57BL/6J, BALB/cJ, Sprague-Dawley)

Anxiety-Like BehaviorImmediate
Fear ResponseInnate (no conditioning needed)
HPA DysregulationAcute HPA activation
Test Window24 hours to 7 days post-exposure

Exposure to predator-derived stimuli (cat fur, fox urine TMT, or 2MT synthetic predator odor) triggers innate defensive behaviors without prior learning. Produces acute freezing, avoidance, and risk assessment during exposure, followed by sustained anxiety-like behavior lasting hours to days. Some animals show PTSD-like sensitization. The model engages amygdala, BNST, and hypothalamic defense circuits that bypass cortical processing.

Ideal for: Innate anxiety circuits; BNST and amygdala research; models where conditioning history is a confound; ethologically relevant fear without shock.

Takahashi LK, et al. (2005). The smell of danger: A behavioral and neural analysis of predator odor-induced fear. Neurosci Biobehav Rev, 29(8), 1157-1167. PMID: 16095694

Predator Odor Behavioral Battery

Elevated Plus Maze

Testing 24 hours after predator odor exposure reveals sustained anxiety-like behavior — reduced open arm time persists for days in susceptible animals.

View Elevated Plus Maze

Light-Dark Box

Predator odor-exposed mice show increased dark zone time. Light-dark transitions decrease, reflecting heightened avoidance of exposed environments.

View Light-Dark Box

Open Field Test

Thigmotaxis increases and center exploration decreases following predator odor exposure. Total distance may decrease (freezing) or increase (flight) depending on protocol timing.

View Open Field Test

Zero Maze

Reduced open quadrant time following predator odor exposure. The annular design eliminates center zone ambiguity for cleaner anxiety quantification.

View Zero Maze

Fear Conditioning

Predator odor pre-exposure can sensitize subsequent fear conditioning — enhanced fear acquisition and impaired extinction. Tests whether innate fear predisposes to PTSD-like associative fear.

View Fear Conditioning System

Behavioral Test Battery by Model

Which tests are validated for each model. Build your protocol by selecting from recommended assays.

TestDiazepam ValidationChronic CorticosteroneSPS (PTSD)Predator Odor
Elevated Plus Maze
Light-Dark Box
Open Field Test
Zero Maze
Novel Object Recognition
Fear Conditioning (Extinction)
Acoustic Startle
Fear Conditioning

Behavioral Testing Equipment

Purpose-built equipment for Anxiety Disorders preclinical research. Each product ships with protocol documentation and technical support from PhD scientists.

Elevated Plus Maze

Elevated Plus Maze

Four-arm elevated maze with open and closed arms. The gold standard for anxiety-like behavior assessment across all anxiety models.

Light-Dark Box

Light-Dark Box

Two-compartment apparatus with illuminated and dark zones. Approach-avoidance conflict assay for anxiety-like behavior with simple, rapid protocol.

Zero Maze

Zero Maze

Elevated annular maze with alternating open and closed quadrants. Eliminates center zone ambiguity of the plus maze for cleaner anxiety measurement.

Open Field Test

Open Field Test

Arena for locomotor activity, thigmotaxis, and center zone exploration. Essential baseline control and anxiety-like behavior measure.

Fear Conditioning System

Fear Conditioning System

Automated chamber with shock grid, auditory cue, and video tracking. Critical for fear acquisition and extinction protocols in PTSD models.

Acoustic Startle Chamber

Acoustic Startle Chamber

Sound-attenuated chamber for acoustic startle reflex and prepulse inhibition. Measures hyperarousal and sensorimotor gating deficits in PTSD models.

Novel Object Recognition

Novel Object Recognition

Arena with standardized object sets for recognition memory. Links anxiety to hippocampal cognitive impairment in chronic models.

Frequently Asked Questions

What is the best mouse model for anxiety research?

For anxiolytic drug screening, start with diazepam validation on the elevated plus maze — this establishes assay sensitivity. For sustained GAD-like anxiety, chronic corticosterone produces reliable anxiety phenotypes over 4–7 weeks. For PTSD, single prolonged stress (SPS) uniquely recapitulates impaired fear extinction and enhanced negative feedback of the HPA axis. Predator odor engages innate fear circuits without conditioning, ideal for studying unconditioned anxiety.

What is the difference between the elevated plus maze and zero maze?

Both measure approach-avoidance conflict between exposed (anxiogenic) and enclosed (safe) arms. The elevated plus maze has a center square where all four arms intersect — time spent in this zone is ambiguous (neither open nor closed). The zero maze replaces the intersection with a continuous annular track with alternating open and closed quadrants, eliminating the center zone problem. The zero maze provides cleaner data but is less widely published than the EPM.

How does single prolonged stress model PTSD?

SPS combines three sequential stressors (2 hours restraint, 20 minutes forced swim, ether until unconsciousness) followed by 7 days of isolation. This produces the neuroendocrine signature of PTSD: enhanced negative feedback of the HPA axis, with low baseline cortisol and exaggerated dexamethasone suppression. Behaviorally, SPS animals show enhanced fear acquisition, impaired fear extinction, exaggerated startle, and anxiety-like behavior — matching the DSM-5 PTSD symptom clusters.

Can anxiety and depression be studied in the same mouse model?

Yes. Chronic corticosterone produces both anxiety-like behavior (reduced open arm time on EPM, increased thigmotaxis) and depressive phenotypes (anhedonia on sucrose preference, increased immobility on FST). Similarly, CUMS produces anxiety alongside anhedonia. This comorbidity mirrors clinical populations where ~60% of patients with MDD also meet criteria for an anxiety disorder. Using models that produce both phenotypes is more clinically relevant than studying either in isolation.

What behavioral tests are used for anxiety in mice?

The core anxiety battery includes the elevated plus maze (open/closed arm conflict), light-dark box (illumination avoidance), open field (center zone exploration and thigmotaxis), and zero maze (annular open/closed conflict). For PTSD specifically, add fear conditioning with extinction trials and acoustic startle with prepulse inhibition. All assays are based on the approach-avoidance conflict principle — anxiety is quantified by avoidance of exposed, bright, or novel environments.

Why is predator odor used to study anxiety?

Predator odor (cat fur, fox urine TMT, or synthetic 2MT) triggers innate defensive behaviors without any prior conditioning or learning. This engages hardwired amygdala, BNST, and hypothalamic circuits that evolved for predator defense. The advantage over conditioned fear models is ecological validity — you are studying anxiety-relevant circuits without the confound of associative learning history. Predator odor can also sensitize subsequent conditioned fear, making it useful for studying vulnerability to PTSD-like fear learning.